News

Assessment of Lump sum funding in Horizon 2020 and Horizon Europe- Commission report published

Published on | 11 months ago

Programmes Horizon Europe HorizonEU L+F H2020 L+F

The Commission published their recent report based on analysis of implementation data and feedback from surveys.

A summary is also available here.

According to the Commission, the new report confirms that:

  1. ·lump sum funding continues to be popular with users
  2. ·lump sums are perceived as reducing the administrative burden
  3. ·concerns of some stakeholder groups have not materialised.

The report describes the state of play in early 2024, with nearly 1 400 lump sum grants signed and many of them completed.

The previous assessment of lump sum funding was published in 2021

 

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1670 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.